Siga Technologies (SIGA) Current Deferred Revenue (2016 - 2025)
Siga Technologies' (SIGA) quarterly Current Deferred Revenue came in at $10.2 million in Q4 2025, down 0.88% YoY from $10.3 million in Q4 2024, and little changed on a QoQ basis from $10.2 million in Q3 2025.
Siga Technologies (SIGA) Current Deferred Revenue (2016 - 2025) Analysis & Trends
Siga Technologies (SIGA) has 10 years of Current Deferred Revenue data on file, last reported at $10.2 million in Q4 2025.
- Quarterly Current Deferred Revenue fell 0.88% year-over-year to $10.2 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $10.2 million (down 0.88% YoY) and the FY2025 annual result came in at $10.2 million, down 0.88% from the prior year.
- Current Deferred Revenue was little changed at $10.2 million in Q4 2025, from $10.2 million in the prior quarter.
- In the past five years, Current Deferred Revenue ranged from a high of $21.9 million in Q3 2023 to a low of $300000.0 in Q4 2022.
- A 5-year average of $10.1 million and a median of $10.2 million in 2025 frame the typical range for Current Deferred Revenue.
- Annual changes were most pronounced in 2022 — Current Deferred Revenue sank 90.62% — and 2023, when it jumped 6829.57%.
- Tracing SIGA's Current Deferred Revenue over 5 years: stood at $3.2 million in 2021, then slumped by 90.62% to $300000.0 in 2022, then jumped by 6829.57% to $20.8 million in 2023, then sank by 50.31% to $10.3 million in 2024, then dropped by 0.88% to $10.2 million in 2025.
- The last three Current Deferred Revenue figures came in at $10.2 million (Q4 2025), $10.2 million (Q3 2025), and $10.2 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn |
| 3 | Zoetis | 31.79 Bn | 30.11 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.69 Bn | 22.89 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.25 Bn | 19.58 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - |
| 10 | Siga Technologies | 212.31 Mn | 57.34 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 10.24 Mn |
| Sep 30, 2025 | 10.24 Mn |
| Jun 30, 2025 | 10.24 Mn |
| Mar 31, 2025 | 10.33 Mn |
| Dec 31, 2024 | 10.33 Mn |
| Sep 30, 2024 | 13.73 Mn |
| Jun 30, 2024 | 13.70 Mn |
| Mar 31, 2024 | 20.50 Mn |
| Dec 31, 2023 | 20.79 Mn |
| Sep 30, 2023 | 21.90 Mn |
| Jun 30, 2023 | 11.37 Mn |
| Mar 31, 2023 | 10.52 Mn |
| Dec 31, 2022 | 300,000.00 |
| Sep 30, 2022 | 10.13 Mn |
| Jun 30, 2022 | 7.04 Mn |
| Mar 31, 2022 | 793,464.00 |
| Dec 31, 2021 | 3.20 Mn |
| Sep 30, 2021 | 3.59 Mn |
| Mar 31, 2021 | 3.57 Mn |
| Dec 31, 2020 | 3.28 Mn |